Fundraising Fox
Synaptrix
Alpharetta, US · Founded 2022 · Delaware corporation · 2 known investors
Find your way into Synaptrix
Sign up to see every warm intro you have to Synaptrix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synaptrix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Synaptrix develops NOVABLOC, a non-opioid neuromodulation therapy that uses electrical stimulation to provide targeted, long-lasting postoperative pain relief. The device is being evaluated in a US randomized controlled trial for perioperative pain management, aiming to reduce opioid use after surgeries such as knee replacement.
Founders & leadership
SS
Shyamy SastryExecutive
Board
DR
Doug ReedBoard director
RC
Robert CrutchfieldBoard director
AW
Investors · 2
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2024
▶$10MraisedNov 2024 · 11 investors · Other TechnologyRule 506(b)
▶$10MraisedNov 2024 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Doug ReedDirector
- Shyamy SastryExecutive Officer, Director
- Kurt JacobusDirector
- Robert CrutchfieldExecutive Officer, Director
- Anita WatkinsDirector
- Offering amount
- $15M
- Amount sold
- $10M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Meduloc Medical Devices & EquipmentMeduloc develops minimally invasive intramedullary implants for internal fixation of small and long-bone fractures. Its products are intended for orthopedic surgeons treating fracture patients in the medical device field.
Companies working in the same space as Synaptrix.
Frequently asked questions
- What does Synaptrix do?
- Synaptrix develops NOVABLOC, a non-opioid neuromodulation therapy that uses electrical stimulation to provide targeted, long-lasting postoperative pain relief. The device is being evaluated in a US randomized controlled trial for perioperative pain management, aiming to reduce opioid use after surgeries such as knee replacement.
- Who are Synaptrix's investors?
- Synaptrix's investors include Hatteras Venture Partners, Portal Innovations.
- How much funding has Synaptrix raised?
- Synaptrix has disclosed $10M raised across 1 round.
- Where is Synaptrix headquartered?
- Synaptrix is headquartered in Alpharetta, US.